无论如何都会发生什么?估算免疫接种后不良事件背景发生率时的人群数据源考量
该回顾性队列分析利用2015至2019年医院入院、急诊就诊和全科诊所咨询数据,估算37种特殊关注不良事件(AESI)的背景发生率,并按接种后1天、1周和6周计算预期巧合病例数,评估不同数据源对各AESI背景率估算的贡献。
要点
- 37种AESI共识别16,437,156例次,医院入院数据主要贡献19种(51%)AESI的背景率估算。
- 8种(22%)AESI主要由初级保健数据提供信息,10种(27%)由多来源混合提供。
- 4种AESI(过敏性荨麻疹、贝尔麻痹、多形红斑和猝死)急诊就诊数据优于入院数据,但11种(30%)AESI未在ICD-10编码急诊数据中捕获。
核心结论
- 理解当地背景发生率有助于新疫苗广泛接种时的安全信号检测并维持公众对疫苗接种的信心。
- 医院和初级保健数据源可用于估算接种后可能发生的不良事件预期背景发生率。
- 需根据疾病性质和就诊医疗场所来理解哪个数据源提供最佳信息。
研究设计与样本
- 回顾性队列分析,纳入2015至2019年(COVID-19、Mpox或Shingrix疫苗接种引入前)的医院入院、急诊就诊和全科诊所咨询数据。
- 估算37种特殊关注不良事件(AESI)的背景发生率,按每10万人口计算,并按接种后1天、1周和6周及生命阶段年龄组和就诊医疗场所呈现预期巧合病例数。
- 评估每个数据源对各AESI背景率估算的比例贡献。
主要发现
- 37种AESI共识别16,437,156例次。
- 医院入院数据主要贡献19种(51%)AESI的背景率估算,包括 exclusively ADEM 和CVST。
- 8种AESI(22%)主要由初级保健数据提供信息,10种(27%)由多来源混合提供。
- 4种AESI(过敏性荨麻疹、贝尔麻痹、多形红斑和猝死)急诊就诊数据优于入院数据,但11种(30%)AESI未在ICD-10编码急诊数据中捕获。
临床怎么用
- 作者认为,医院和初级保健数据源可用于估算接种后可能发生的不良事件预期背景发生率。
- 作者认为,需根据疾病性质和就诊医疗场所来理解哪个数据源提供最佳信息。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Understanding background incident rates of adverse events following immunisation (AEFI) is essential to rapidly detect, evaluate, respond to, and communicate about vaccine safety concerns, especially for new vaccines. Creating estimates based on geographic specific population level data is increasingly important, as new AEFI presentations will be subject to the same local influences of population demography, exposures, health system variations and level of health care sought. METHODS: We conducted a retrospective cohort analysis of hospital admissions, emergency department presentations and general practice consultations from 2015 to 2019-before introduction of COVID-19, Mpox or Shingrix vaccination-to estimate background incident rates for 37 conditions considered potential AEFI of special interest (AESI). Background incident rates per 100,000 population were calculated and presented as cases expected to occur coincidentally 1 day, 1 week and 6 weeks post-vaccination, by life-stage age-groups and presenting healthcare setting. We then assessed the proportional contribution of each data source to inform each AESI background rate estimate. RESULTS: 16,437,156 episodes of the 37 AESI were identified. Hospital admissions predominantly informed 19 (51%) of AESI, including exclusively ADEM and CVST; 8 AESI (22%) by primary care, and 10 (27%) a mix. Four AESI (allergic urticaria, Bell's palsy, erythema multiform and sudden death) were better informed by emergency presentations than admissions, but conversely 11 AESI (30%) were not captured in ICD-10 coded emergency presentations at all. CONCLUSIONS: Emergent safety concerns are inevitable in population-wide implementation of new vaccines, therefore understanding local background rates aids both safety signal detection as well as maintaining public confidence in vaccination. Hospital and primary care data sources can be interrogated to inform expected background incident rates of adverse events that may occur following vaccination. However, it is necessary to understand which data-source provides best intelligence according to nature of condition and presenting healthcare setting.
引用
- Clothier HJ, Shetty AN, Mesfin Y, et al. What would have happened anyway? Population data source considerations when estimating background incident rates of adverse events following immunisation to inform vaccine safety. Vaccine. 2024. PMID: 38262811. doi:10.1016/j.vaccine.2024.01.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。